Breaking News Instant updates and real-time market news.

F

Ford

$9.20

0.14 (1.55%)

17:41
10/23/19
10/23
17:41
10/23/19
17:41

Ford says Explorer SUV launch 'fell short in a few ways'

Says Explorer SUV launch "fell short in a few ways." Says "took on too much" with complicated Explorer rollout.

  • 23

    Oct

F Ford
$9.20

0.14 (1.55%)

09/10/19
BOFA
09/10/19
NO CHANGE
Target $13
BOFA
Buy
Ford downgrade by Moody's may be sign of things to come, says BofA/Merrill
BofA Merrill Lynch analyst John Murphy said Ford's corporate borrowing costs will likely remain unchanged in the near-term despite Moody's downgrade of the company's senior unsecured rating to Ba1, or a junk status, since Ford faces no significant near-term debt maturities. While the financial implications seem "somewhat de minimis at present," Moody's move on Ford's credit rating could be a harbinger of future downgrades for the company and even for the broader automotive value chain, particularly for those undergoing turnaround efforts, said Murphy. While he does not disagree with many of the concerns raised by Moody's, Murphy thinks Ford's dividend will be maintained for the foreseeable future and views the near-term product cycle as robust. He also believes improved execution and communication may help Ford's multiple to recover despite the "somewhat disappointing" downgrade news, leading Murphy to keep a Buy rating on Ford shares.
09/18/19
MSCO
09/18/19
NO CHANGE
Target $12
MSCO
Overweight
Ford details on EVs, cost savings to be catalysts, says Morgan Stanley
Morgan Stanley analyst Adam Jonas, in a note to investors titled "Ford Ready to Shock with BEV and Cost Savings?," said his conviction has increased, based on investor positioning and low expectations for Ford in the equity and debt market, that the company offering details around its battery electric vehicle plans and cost savings expectations can be catalysts for the stock. Ford has communicated $11B of restructuring charges, but hasn't made clear any annual savings targets so that consensus forecasts don't include them, Jonas said. He currently gives Ford credit for roughly $1B of restructuring savings and expects the company to outline its savings forecasts to the investment community within the next two quarters. Jonas, who also expect Ford's electrification strategy to shift from hybrids to battery electric over the next 24 months, reiterated his Overweight rating and $12 price target on Ford shares.
09/27/19
MSCO
09/27/19
NO CHANGE
Target $12
MSCO
Overweight
Ford Q3 may lack 'punch,' but weakness would be opportunity, says Morgan Stanley
Morgan Stanley analyst Adam Jonas lowered his 2019 EPS forecast for Ford to $1.22 from $1.30 to account for his inclusion of estimated UAW contract ratification costs and also pointed to headwinds related to a challenging ramp-up of Explorer in Q3 and more losses from China imports in the second half. While he thinks Ford's Q3 report "may not pack a big punch," Jonas would see any related weakness in Ford shares as a buying opportunity as he is attracted to low expectations for Ford in the equity and debt markets. Jonas, who added that he likes the current setup for Ford "very much," reiterated his Overweight rating and $12 price target on the shares.
10/01/19
BUCK
10/01/19
NO CHANGE
Target $8
BUCK
Neutral
Ford price target lowered to $8 from $9 at Buckingham
Buckingham analyst Joseph Amaturo maintained a Neutral rating on Ford and lowered his price target to $8 from $9, citing a more cautious view of earnings per share and free cash flow for the second half of the year as well as heightened concerns for 2020. Amaturo tells investors in a research note that he is "pretty confident" Ford will fall meaningfully short of EPS and adjusted free cash flow expectations for the third quarter when it reports on October 23, and says he is becoming increasingly concerned about end market demand in many of the markets it participates in.

TODAY'S FREE FLY STORIES

14:28
11/18/19
11/18
14:28
11/18/19
14:28
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

GSB

GlobalSCAPE

$10.13

0.08 (0.80%)

14:26
11/18/19
11/18
14:26
11/18/19
14:26
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$67.76

-0.63 (-0.92%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Options
Cerner call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRHC

Tabula Rasa HealthCare

$41.26

-0.83 (-1.97%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Conference/Events
Tabula Rasa HealthCare participates in a conference call with Benchmark »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

DNA

Bought by RHHBY

$0.00

(0.00%)

14:23
11/18/19
11/18
14:23
11/18/19
14:23
Conference/Events
Wolfe Research pharma analyst to hold an analyst/industry webcast »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:18
11/18/19
11/18
14:18
11/18/19
14:18
Recommendations
MorphoSys analyst commentary  »

MorphoSys B-MIND futility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/18/19
11/18
14:17
11/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/18/19
11/18
14:16
11/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:14
11/18/19
11/18
14:14
11/18/19
14:14
Hot Stocks
MorphoSys says tafasitamab B-MIND study successfully passed futility analysis »

Earlier, MorphoSys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

DISCA

Discovery

$30.74

1.03 (3.47%)

14:03
11/18/19
11/18
14:03
11/18/19
14:03
Hot Stocks
Discovery rises after Malone buys $75M worth of stock »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$196.73

1.66 (0.85%)

14:01
11/18/19
11/18
14:01
11/18/19
14:01
Options
Call volume jumps in Facebook as shares and implied volatility lift »

Call volume jumps in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

ABMD

Abiomed

$190.75

-32.48 (-14.55%)

13:54
11/18/19
11/18
13:54
11/18/19
13:54
Hot Stocks
Abiomed falls after studies question Impella heart device at AHA 2019 meeting »

In a story out over the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNI

McClatchy

$0.56

0.0846 (17.63%)

13:53
11/18/19
11/18
13:53
11/18/19
13:53
Hot Stocks
Bluestone Financial raises stake in McClatchy to 11.85% »

Bluestone Financial holds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSII

Heidrick & Struggles

$29.39

-0.04 (-0.14%)

13:50
11/18/19
11/18
13:50
11/18/19
13:50
Initiation
Heidrick & Struggles initiated  »

Heidrick & Struggles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

13:50
11/18/19
11/18
13:50
11/18/19
13:50
General news
Fed's Mester said she would have preferred to have kept rates steady »

Fed's Mester said…

CL

Colgate-Palmolive

$67.08

0.71 (1.07%)

13:45
11/18/19
11/18
13:45
11/18/19
13:45
Options
Colgate Palmolive call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRTX

Karuna Therapeutics

$73.20

55.94 (324.10%)

13:43
11/18/19
11/18
13:43
11/18/19
13:43
Recommendations
Karuna Therapeutics analyst commentary  »

Karuna Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

STNE

StoneCo

$37.17

-0.73 (-1.93%)

13:35
11/18/19
11/18
13:35
11/18/19
13:35
Options
StoneCo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

13:35
11/18/19
11/18
13:35
11/18/19
13:35
General news
Treasury Action: yields remain modestly lower on the day »

Treasury Action: yields…

I

Intelsat

$11.26

-2.14 (-15.97%)

13:29
11/18/19
11/18
13:29
11/18/19
13:29
Hot Stocks
CBA responds to announcement by FCC Chair regarding C-band spectrum proceeding »

The C-Band Alliance, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ARWR

Arrowhead

$48.38

0.95 (2.00%)

13:27
11/18/19
11/18
13:27
11/18/19
13:27
Recommendations
Arrowhead analyst commentary  »

Arrowhead data validates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.27

-0.27 (-0.61%)

13:25
11/18/19
11/18
13:25
11/18/19
13:25
Hot Stocks
Altitude Sports files antitrust suit against Comcast »

Altitude Sports &…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.27

-0.27 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

EQT

EQT Corporation

$9.70

-0.64 (-6.19%)

13:25
11/18/19
11/18
13:25
11/18/19
13:25
Options
EQT Corporation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

AGIO

Agios Pharmaceuticals

$36.81

1.17 (3.28%)

, ETNB

89bio

$27.29

1.26 (4.84%)

13:25
11/18/19
11/18
13:25
11/18/19
13:25
On The Fly
Fly Insider: 89Bio, Addus Homecare among week's notable insider trades »

Welcome to "Fly Insider,"…

AGIO

Agios Pharmaceuticals

$36.81

1.17 (3.28%)

ETNB

89bio

$27.29

1.26 (4.84%)

GRTX

Galera Therapeutics

$12.06

0.11 (0.92%)

ARVN

Arvinas

$31.31

0.89 (2.93%)

TRN

Trinity Industries

$20.92

-0.295 (-1.39%)

ADUS

Addus HomeCare

$85.34

1.07 (1.27%)

AL

Air Lease

$44.90

-0.58 (-1.28%)

AMED

Amedisys

$155.36

2.65 (1.74%)

BLKB

Blackbaud

$83.98

0.23 (0.27%)

BOKF

BOK Financial

$81.03

-0.88 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

  • 13

    Dec

ZEN

Zendesk

$76.48

1.05 (1.39%)

13:22
11/18/19
11/18
13:22
11/18/19
13:22
Hot Stocks
Helpshift announces integration with Amazon Connect »

Helpshift announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.